Genomic features underlying meningioma sex-specificity
- PMID: 39776156
- PMCID: PMC12083219
- DOI: 10.1093/neuonc/noaf002
Genomic features underlying meningioma sex-specificity
Conflict of interest statement
DRR has received honoraria for consultation from the following for-profit companies: Tipping Point, Gamma Tile, Boston Scientific, Nerviano Medical Science, and Keller Postman.
Comment on
-
Meningiomas: Sex-specific differences and prognostic implications of a chromosome X loss.Neuro Oncol. 2025 May 15;27(4):1019-1028. doi: 10.1093/neuonc/noae239. Neuro Oncol. 2025. PMID: 39535060
References
-
- Peyre M, Gaillard S, de Marcellus C, et al. Progestin-associated shift of meningioma mutational landscape. Ann Oncol. 2018; 29(3):681–686. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
